Less discontinuation of ADHD drug use since the availability of long-acting ADHD medication in children, adolescents and adults under the age of 45 years in the Netherlands

Treatment options for ADHD in the Netherlands have increased with the introduction of the extended-release formulations of methylphenidate (MPH ER, Concerta(®)) in 2003 and atomoxetine (ATX, Strattera(®)) in 2005, but data on the effect on drug usage patterns are scarce. The objective of the present...

Descripción completa

Detalles Bibliográficos
Autores principales: van den Ban, Els, Souverein, Patrick C., Swaab, Hanna, van Engeland, Herman, Egberts, Toine C. G., Heerdink, Eibert R.
Formato: Texto
Lenguaje:English
Publicado: Springer Vienna 2010
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3000908/
https://www.ncbi.nlm.nih.gov/pubmed/21258431
http://dx.doi.org/10.1007/s12402-010-0044-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3000908/
https://www.ncbi.nlm.nih.gov/pubmed/21258431
http://dx.doi.org/10.1007/s12402-010-0044-9

Ejemplares similares